Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
Methotrexate
Sulfasalazine
+25 more
Locations
1
United States
NYU Langone Health
New York, New York, United States
Start Date
September 1, 2025
Primary Completion Date
September 1, 2027
Completion Date
September 1, 2027
Last Updated
August 24, 2025
NCT00024479
NCT07469787
NCT04402086
NCT06870045
NCT05786235
NCT04890483
Lead Sponsor
NYU Langone Health
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions